These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 28035923)

  • 1. Neural Correlates of Self-Reference Effect in Early Alzheimer's Disease.
    Gaubert M; Villain N; Landeau B; Mézenge F; Egret S; Perrotin A; Belliard S; de La Sayette V; Eustache F; Desgranges B; Chételat G; Rauchs G
    J Alzheimers Dis; 2017; 56(2):717-731. PubMed ID: 28035923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-reference effect on memory in healthy aging, mild cognitive impairment and Alzheimer's disease: Influence of identity valence.
    Leblond M; Laisney M; Lamidey V; Egret S; de La Sayette V; Chételat G; Piolino P; Rauchs G; Desgranges B; Eustache F
    Cortex; 2016 Jan; 74():177-90. PubMed ID: 26691733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D; Schuff N; Jagust W; Weiner MW;
    Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
    Fleisher AS; Chen K; Liu X; Roontiva A; Thiyyagura P; Ayutyanont N; Joshi AD; Clark CM; Mintun MA; Pontecorvo MJ; Doraiswamy PM; Johnson KA; Skovronsky DM; Reiman EM
    Arch Neurol; 2011 Nov; 68(11):1404-11. PubMed ID: 21747008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.
    Villain N; Chételat G; Grassiot B; Bourgeat P; Jones G; Ellis KA; Ames D; Martins RN; Eustache F; Salvado O; Masters CL; Rowe CC; Villemagne VL;
    Brain; 2012 Jul; 135(Pt 7):2126-39. PubMed ID: 22628162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive and neuroimaging evidence of impaired interaction between self and memory in Alzheimer's disease.
    Genon S; Bahri MA; Collette F; Angel L; d'Argembeau A; Clarys D; Kalenzaga S; Salmon E; Bastin C
    Cortex; 2014 Feb; 51():11-24. PubMed ID: 23993283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging characteristics and safety of florbetapir (¹⁸F) in Japanese healthy volunteers, patients with mild cognitive impairment and patients with Alzheimer's disease.
    Namiki C; Takita Y; Iwata A; Momose T; Senda M; Okubo Y; Joshi AD; Lu M; Agbulos A; Breault C; Pontecorvo MJ
    Ann Nucl Med; 2015 Aug; 29(7):570-81. PubMed ID: 25943346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The self-reference effect in dementia: Differential involvement of cortical midline structures in Alzheimer's disease and behavioural-variant frontotemporal dementia.
    Wong S; Irish M; Leshikar ED; Duarte A; Bertoux M; Savage G; Hodges JR; Piguet O; Hornberger M
    Cortex; 2017 Jun; 91():169-185. PubMed ID: 27771044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neural evidence for defective top-down control of visual processing in Parkinson's and Alzheimer's disease.
    Nemcova Elfmarkova N; Gajdos M; Rektorova I; Marecek R; Rapcsak SZ
    Neuropsychologia; 2017 Nov; 106():236-244. PubMed ID: 28974380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Female Advantage in Verbal Memory Contribute to Underestimating Alzheimer's Disease Pathology in Women versus Men?
    Sundermann EE; Biegon A; Rubin LH; Lipton RB; Landau S; Maki PM;
    J Alzheimers Dis; 2017; 56(3):947-957. PubMed ID: 28106548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity.
    Avants BB; Hutchison RM; Mikulskis A; Salinas-Valenzuela C; Hargreaves R; Beaver J; Chiao P;
    Neurobiol Aging; 2019 Feb; 74():191-201. PubMed ID: 30471630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Famous faces and voices: Differential profiles in early right and left semantic dementia and in Alzheimer's disease.
    Luzzi S; Baldinelli S; Ranaldi V; Fabi K; Cafazzo V; Fringuelli F; Silvestrini M; Provinciali L; Reverberi C; Gainotti G
    Neuropsychologia; 2017 Jan; 94():118-128. PubMed ID: 27916672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.
    Joshi AD; Pontecorvo MJ; Clark CM; Carpenter AP; Jennings DL; Sadowsky CH; Adler LP; Kovnat KD; Seibyl JP; Arora A; Saha K; Burns JD; Lowrey MJ; Mintun MA; Skovronsky DM;
    J Nucl Med; 2012 Mar; 53(3):378-84. PubMed ID: 22331215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-Reference Effect and Self-Reference Recollection Effect for Trait Adjectives in Amnestic Mild Cognitive Impairment.
    Carson N; Rosenbaum RS; Moscovitch M; Murphy KJ
    J Int Neuropsychol Soc; 2018 Sep; 24(8):821-832. PubMed ID: 30064540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.